Biosimilars Congress 2019 is included Keynote and Speakers sessions on the most recent
examination intended to offer extensive worldwide exchanges that address
current issues in Biosimilars Congress 2019
The success of innovator
biologicals with downsides of high costs and patents expiring have
contributed to development of Biosimilars coupled with advantage of
regulations, adaptability by physicians and patients. Biosimilars being complex
molecules need to have sound scientific strategic approach to development,
manufacturing and research. Few legal issues have not dampened Biosimilar
companies to have strong pipelines, quality and focused timelines to provide
affordable and effective drugs to patients in need.
Biosimilars - The generic version of biologicals is not only an
emerging trend but has paved its way to succeed and sustain in the world of
pharmaceuticals. Biosimilars take credit for revolutionizing the development of
targeted, effective and affordable biologic treatments required across various
therapeutic areas like Oncology, Immunology,
Endocrinology,
Ophthalmology
etc. This need has attracted major investors as the prospects are driven by
streamlined regulatory guidelines with high adoption rate amongst physicians
and patients.
·
Biotechnology medicinal products for different drugs
·
Future
of next generation biosimilars
·
Biopharmaceuticals development
·
Biotechnology
medicinal products for different drugs
Submit
your abstract to any of the mentioned tracks.
Register
now for the conference by choosing an appropriate package suitable to
you.